About PHARMIgA
Most therapeutic antibodies currently used to treat disease are based on a single antibody class: IgG. While highly effective in the bloodstream, IgG antibodies are often less effective at mucosal surfaces such as the lungs and gastrointestinal tract. These tissues are central to major unmet medical needs, including respiratory infections, inflammatory diseases, and several forms of cancer.
In contrast, IgA antibodies are naturally abundant at mucosal surfaces, where they play a key role in immune defense. IgA can efficiently neutralize pathogens and engage immune cells through mechanisms distinct from IgG. Despite their therapeutic potential, very few IgA-based therapeutics have reached the clinic. Development remains technically challenging due to complex production processes, limited scalable manufacturing methods, and the lack of standardized models and infrastructure.
PHARMIgA was established to address these challenges by bringing together expertise, technologies, and facilities within a single collaborative network. Rather than focusing on one specific therapeutic candidate, the consortium aims to develop a comprehensive platform and toolbox that will accelerate the discovery, production, and translation of IgA-based therapeutics.
The consortium combines expertise from Utrecht University and University Medical Center Utrecht, in collaboration with Sanquin and PD-Value, as well as partners across the Utrecht Science Park and industrial collaborators from the biotechnology, pharmaceutical, and nutrition sectors.
The Role
In this hands-on laboratory position, you will work closely with the postdoctoral researcher and consortium partners on the production, purification, characterization, and optimization of IgA antibodies. You will contribute directly to the day-to-day execution of experiments and help establish robust workflows for generating and analyzing different IgA formats.
Responsibilities
The PHARMIgA research program is structured around four interconnected pillars:
This technician position is embedded within the second pillar and will support the development, optimization, and production of IgA antibody formats in close collaboration with the postdoctoral researcher leading this work. This postion will be embedded in the AntibodyTherapy group of prof. Jeanette Leusen, consisting of 3 assistant profs, 2 post-docs, 10 research technicians, 7 PhD students and several master students. This group is part of the Center for Translational Immunology (CTI).
Wij geloven in de kracht van een divers team waarin ruimte is voor verschillende vaardigheden, expertises, sociale en culturele achtergronden. Wij zijn benieuwd naar jou!
Onze nieuwe collega's werven we zelf. We hebben geen behoefte aan acquisitie.
Meld je aan om reviews, anonieme beoordelingen en salarisgegevens te bekijken voordat je solliciteert.